Deuterium Depletion in Life Science

Depletion of body deuterium (D) can simply be achieved by consumption or prolonged administration of deuterium-depleted water (DDW) and nutrients deficient in D. It was therefore postulated that D-depletion would have therapeutic use in patients with cancer and other neoplastic diseases. In subsequent toxicology studies DDW appeared to be completely safe and non-toxic when given to mice in place of regular water for several months. Following preclinical safety and efficacy studies, a Phase II double blind randomized clinical trial was initiated to evaluate the potential usefulness of therapeutic efficacy and safety of DDW in patients with prostate tumor.

2nd International Congress on Deuterium Depletion

After the succes of the 1st International Symposium on Deuterium Depletion which took place in 2010, the 2nd International Congress on Deuterium Depletion wishes to give the researchers and medical practitioners a new opportunity to get acquainted with this expanding field of science and share their results and experience. In this frame, the goal of the organizers is to provide a global and comprehensive update of the newest results and developments in the research of deuterium depletion. (www.deuteriumdepletion.com)